🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👉👉👉Honored to join my colleagues as invited speakers for an MPN-focused Research TownHall on Myelofibrosis new directions- please join us ! #MPNSM | Stephen Oh | Prithviraj Bose Naveen Pemmaraju, MD Lucia Masarova, MD Sanam Loghavi, MD صنم لغوی 🔬🧬 | MD Anderson Cancer Center #endcancer | Ruben A. Mesa, MD Naval Daver, M.D.

🙌 ICYMI: CK0801, an allogeneic T regulatory cell therapy, demonstrated safety and efficacy in patients with #myelofibrosis with suboptimal responses to prior therapy. 📰➡️ buff.ly/3zEqTUG Tapan Kadia Naveen Pemmaraju, MD Nitin Jain Naval Daver, M.D. Lucia Masarova, MD MD Anderson Cancer Center

👉👉👉 Proud to have Our MDACC Clinical MPN team nicley represented on the podium today at our inaugural #MPNWorkshopNC24 meeting #MPNSM meeting! Naveen Pemmaraju, MD Prithviraj Bose Lucia Masarova, MD | Ruben A. Mesa, MD Elf Lab 🇺🇦🏳️‍🌈🏳️‍⚧️⚧️👊🏾👊🏽🌈🟧 Anand Patel Ami Patel, MD | Heme Reports | MD Anderson Cancer Center #endcancer

Always a pleasure to talk to VJHemOnc! Excellent job of spreading #MPN data & awareness 👏🫠

Happy to see our trial of DAC, venetoclax and ponatinib for advanced phase CML published in The Lancet Haematology. Response rate was 80%, allowing for bridge to alloSCT. Still a lot more work to be done in this rare disease. We have new TKI combo studies now open and enrolling.

Review on #AML therapy MD Anderson Cancer Center #Leukemia Blood Cancer Journal doi.org/10.1038/s41408… #leusm

It is with deep sorrow that we bid our brother Emmanuel Almanza-Huante farewell today. A brilliant leukemia physician MD Anderson Cancer Center whose light shone so bright; the world is so much darker now. Please donate to help his family, whom he supported, with costs: gofund.me/f8e20f32

Dr. Almanza was one of the most beautiful human beings and exceptional clinicians. He has touched so many hearts 💗 and will be missed deeply. Emma, Rest in Peace 🙏. You are gone way too early 💔 but you will live in us! Cherished memories forever 💖

Another incredible roundtable with Drs. Prithviraj Bose (Prithviraj Bose), Andrew Kuykendall (Andrew Kuykendall MD), Lucia Masarova (Lucia Masarova, MD), and Francesca Palandri! 🙌 Thank you all for the insightful discussion! Stay updated on the latest from #ASH24: bloodcancerstoday.com/conference/202…

Unique way of approaching #Myelofibrosis with #Tregs; safe and promising efficiency with significant improvement of early satiety, fatigue & MPN symptoms. Excited to learn more about immune deregulation & how to modulate it to improve on patients outcomes! #ASH24

Congratulations to an amazing clinician and researcher Georgio Medawar, MD with admirable passion for hematology 👍 ! Fantastic future ahead 🙏👏 #ASH24

📢 Big Congratulations to Julie Braish; Superstar leukemia fellow and Chief fellow MD Anderson Cancer Center! It has been an absolute pleasure to mentor you!!! Fellow to be Moffitt Cancer Center 👏Abstracts at #ASH23, #ASH24, #ASCO24, #MPNBrooklyn 👏👏. Can't wait to see what is coming next 👍👍

Thanks ASH for another amazing #ASH24 experience!!! 🙏 Full of friends, connections, science, fruitful discussions (a must ☕), oral & poster presentation. All in beautiful 🌞 San Diego 👏👏 #Grateful #EndCancer #hematology

🎉 Out now! 🎉 In this #ASH24 roundtable, Drs. Prithviraj Bose (MD Anderson Cancer Center), Francesca Palandri (Università di Bologna), Andrew Kuykendall MD (Moffitt Cancer Center), and Lucia Masarova, MD (MD Anderson) discuss the current treatment landscape for #myelofibrosis. 📺 Watch here: buff.ly/4gDL6uz

👉👉👉New online Paper alert now avail from our MPN group🚨 longer-term results& #DiseaseModification w/focus addition of #Navitoclax #BCLxL inhibition in patients with #Myelofibrosis || #MPNSM MD Anderson Cancer Center #endcancer | ashpublications.org/bloodneoplasia… Claire Harrison Blood Neoplasia

👉👉👉Important presentation by Ruben A. Mesa, MD for #MPNSM field at #ASCO25 presenting the #SURPASS-ET study : Positive study for #RopegIFN for patients with high-risk randomized ph3 vs Anagrelide for patients intoler/resistant to prior HU in Essential Thrombocytosis | Lucia Masarova, MD ASCO

Ropeginterferon Alfa-2b Demonstrates Superior Efficacy & Safety to Anagrelide as 2L for ET - honored to have shared this yesterday during #ASCO25 ⁦Atrium Health Wake Forest Baptist⁩ Comprehensive Cancer Center ⁦⁦Levine Cancer⁩ ⁦PharmaEssentia⁩ dailynews.ascopubs.org/do/ropeginterf…

👉👉👉Honored to present, on behalf of my co-authors , our Ph2 findings from #CADENZA study #PVEK #CD123 for #BPDCN at #EHA25 #EHA2025 European Hematology Association | Naveen Pemmaraju, MD Naval Daver, M.D. MD Anderson Cancer Center #endcancer #leusm #BPDCN

👉👉👉Congratulations & shout out to Prof Ruben Mesa MD .Ruben A. Mesa, MD & Prof Radek Skoda on being named for the major award for the #ErnestBeutler Lecture & Prize 🏆 🏅 by ASH for 2025 !! 🙌 | #JAK2 #MPNSymptomBurden | #MPNSM | Claire Harrison J.J. Kiladjian MPNCo&D Congress Heme Reports

Looking forward to kicking off an amazing International Consortium for MDS (icMDS) 3rd annual meeting at the #iwMDS2025 #iwMPN2025 with 3 days of packed agenda with top experts & discussions June 27-29. FREE Live streaming available ONLY for health care providers at link VJHemOnc us06web.zoom.us/webinar/regist…